EATG » Access

Access

MPP and USAID sign Memorandum of Understanding

Geneva, 02 November 2017 — The Medicines Patent Pool and the United States Agency for International Development (USAID) signed a Memorandum of Understanding (MoU) to accelerate the introduction of quality,…

Report: TB medicine crisis in Romania

Authorities in Romania are unable to provide the full range of essential medicines needed for the treatment of TB, the Romanian Health Observatory said in its latest report, TB medicine…

MSF secures generic hepatitis C treatment at $120 compared to $147,000 launch price tag

Geneva/Sao Paolo, 31 October 2017—On the eve of the World Hepatitis Summit in Sao Paolo, the international medical humanitarian organization Médecins Sans Frontières (MSF) today announced that it had secured…

Health group challenges Gilead patents in the US on grounds of lack of novelty

A health advocacy group today (October 25) announced that it has challenged a set of United States patents for a hepatitis C medicine. The group says drug maker Gilead Sciences…

Tivicay® and Celsentri® now included in the Essential Drug List in Russia

Both medicines expected to be available in HIV specialist treatment centers from 2018 onwards. London, UK, Tuesday 24 October, 2017 – ViiV Healthcare, a global specialist HIV company with GSK,…

Pills and Profits: How drug companies make a killing out of public research

In this joint report, STOPAIDS and Global Justice Now show how taxpayers are funding billions of pounds worth of research into life-changing drugs – only to be told they are…

TRIPS Council serves as ground for discussion of compulsory licensing

The escalating prices of medicines has become a growing global concern. Among many issues, intellectual property has been pointed to as providing monopolies that allow for unaffordable prices, in particular…

EU to get rid of big pharma-friendly SPCs

Extended monopoly protection by the Regulation EC 469/2009 concerning the supplementary protection certificate (SPC) mechanism for medicinal products has led to spiralling prices in Europe for lifesaving medicines, while exhausting…

Restrictions on free DAA access in many European countries contrary to guidelines and undermine HCV elimination targets, say researchers

The restrictions which many European countries impose on free/reimbursed access to hepatitis C virus (HCV) direct-acting antivirals (DAAs) are contrary to guidelines and undermine the World Health Organization (WHO) goal…

People still being denied improved treatment for multidrug-resistant TB

Médecins Sans Frontières urges governments to step up the use of newer TB drugs. Guadalajara, Mexico, October 13, 2017—People with multidrug-resistant tuberculosis (MDR-TB) are still not receiving two newer TB…